News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
294 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17555)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Drug Development
Results From Alligator Bioscience’s Clinical Phase I Study Support Further Clinical Development of ADC-1013
The study results show that ADC-1013 is generally well tolerated and support further clinical development of ADC-1013 as a mono- or combination therapy.
November 7, 2017
·
5 min read
Biotech Bay
Splunk Machine Learning Helps Recursion Pharmaceuticals Treat Genetic Diseases
With Splunk, Recursion has combined biological science with machine learning to generate and analyze data from tens of thousands of images of cell cultures and trillions of DNA strands.
November 7, 2017
·
4 min read
Business
Dr. Ian McNiece Appointed BioCardia Chief Scientific Officer
Dr. McNiece has spent 30 years in both academic and commercial settings working in the areas of stem cell biology and clinical manufacturing for bone marrow transplantation and cellular therapy clinical applications.
November 7, 2017
·
4 min read
CRH Medical Receives TSX Approval for Normal Course Issuer Bid
CRH Medical announces that it has received approval from the TSX of its Notice of Intention to Make a Normal Course Issuer Bid (the “Bid”).
November 7, 2017
·
11 min read
Baxter Presents Data on the Role of SHARESOURCE Telehealth Platform in Helping the Clinical Management of Peritoneal Dialysis Patients
Presented at the American Society of Nephrology’s annual Kidney Week Congress, Oct. 31- Nov. 5, the exploratory studies show how SHARESOURCE data may provide an early indicator of impending peritonitis, or evidence of PD catheter dysfunction.
November 7, 2017
·
6 min read
Business
Zynex Schedules 2017 Third Quarter Earnings Release and Webcast
The Company expects to file its 2017 third quarter financial results on Monday, November 13, 2017.
November 7, 2017
·
2 min read
Biotech Bay
Jaguar Health Receives Approval From The American Association of Veterinary State Boards RACE Committee for Continuing Education Program for Veterinarians and Veterinary Technicians on Diarrhea in Foals
Jaguar Health announced today that The American Association of Veterinary State Boards (AAVSB) Registry of Approved Continuing Education (RACE) committee has reviewed and approved Jaguar’s “Diarrhea in Foals” continuing education (CE) program as meeting the standards adopted by the AAVSB.
November 7, 2017
·
4 min read
Business
Ionis Names Company Co-Founder as New COO, Effective Jan. 15, 2018
In Monia’s new role, he will be responsible for transitioning research programs into development.
November 7, 2017
·
4 min read
Business
Valeant Announces Third-Quarter 2017 Results
Increased revenue in the Bausch + Lomb/International segment by 1% compared to the third quarter of 2016.
November 7, 2017
·
96 min read
Policy
Newron Pharmaceuticals Announces Advisory Board Recommendations and Rett Congress Findings
At the Rett Congress, Newron’s Burden of Disease advisory board reached a consensus on the concept elicitation interviews which are being used to develop a survey that will be distributed internationally to caregivers and allied healthcare professionals.
November 7, 2017
·
8 min read
Previous
7 of 30
Next